References
Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc. 1957;147:258–267. doi:10.1098/rspb.1957.0048.
Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C American association of liver disease. Hepatology. 2004;39:1147. doi:10.1002/hep.20119.
Jacobson IM. Understanding the interferon molecule. Gastroenterol Hepatol. 2008;4:3–7.
Monzani F, Caraccio N, Dardano A, Ferrannini E. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med. 2004;3:199–210. doi:10.1007/s10238-004-0026-3.
Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25(3):283–291. doi:10.1016/S0168-8278(96)80113-9.
Fabris P, Betterle C, Greggio NA, et al. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol. 1998;28(3):514–517. doi:10.1016/S0168-8278(98)80328-0.
Cozzolongo R, Betterle C, Fabris P, Paola Albergoni M, Lanzilotta E, Manghisi OG. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C. Eur J Gastroenterol Hepatol. 2006;18(6):689–692. doi:10.1097/00042737-200606000-00018.
Schreuder TC, Gelderblom HC, Weegink CJ, et al. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. Liver Int. 2008;28(1):39–46.
Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract. 2001;7(1):52–58.
Wilson LE, Widman D, Dikman SH, Gorevic PD. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum. 2002;32(3):163–173. doi:10.1053/sarh.2002.37277.
Unsworth J, Hutchins P, Mitchell J, et al. Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr. 1982;1:503–513. doi:10.1097/00005176-198212000-00010.
Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5(11):1282–1290. doi:10.1016/j.cgh.2007.05.013.
Casis B, Fernandez-Vazquez I, Barnardos E, et al. Autoimmune enteropathy in an adult with autoimmune multisystemic involvement. Scand J Gastroenterol. 2002;37:1012–1016. doi:10.1080/003655202320378185.
Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. Hum Pathol. 2006;37:373–376. doi:10.1016/j.humpath.2005.11.019.
Ciccocioppo R, D’Alo S, Di Sabatino A, et al. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol. 2002;128:88–93. doi:10.1046/j.1365-2249.2002.01795.x.
Veress B, Franzen L, Bodin L, et al. Duodenal intraepithelial lymphocyte-count revisited. Scand J Gastroenterol. 2004;39:138–144. doi:10.1080/00365520310007675.
Cuenod B, Brousse N, Goulet O, et al. Classification of intractable diarrhea in infancy using clinical and immunohistological criteria. Gastroenterology. 1990;99:1037–1043.
Leon F, Olivencia P, Rodriguez-Pena R, et al. Clinical and immunological features of adult-onset generalized autoimmune gut disorder. Am J Gastroenterol. 2004;99:1563–1571. doi:10.1111/j.1572-0241.2004.40039.x.
Daum S, Sahin E, Jansen A, et al. Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion. 2003;68:86–90. doi:10.1159/000074520.
Oliva-Hemker MM, Loeb DM, Abraham SC, et al. Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. J Pediatr Gastroenterol Nutr. 2003;36:639–643. doi:10.1097/00005176-200305000-00010.
Vanderhoof JA, Young RJ. Autoimmune enteropathy in a child: response to infliximab therapy. J Pediatr Gastroenterol Nutr. 2002;34:312–316. doi:10.1097/00005176-200203000-00018.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gonzalez, G., Castro, F.P., Berho, M. et al. Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C. Dig Dis Sci 55, 1490–1493 (2010). https://doi.org/10.1007/s10620-009-0877-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-0877-2